Article révisé par les pairs
Titre :
  • Cardiac toxicity with anti-HER-2 therapies: what have we learned so far?
Auteur : Azambuja, Evandro ; Bedard, Philippe L ; Suter, T. ; Piccart-Gebhart, Martine
Informations sur la publication : Targeted oncology, 4, 2, (page 77-88)
Statut de publication : Publié, 2009-04
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Anti-HER-2 therapies
Breast cancer
Cardiotoxicity
Lapatinib
Trastuzumab
Mots-clés MeSH : Adjuvants, Immunologic -- administration & dosage
Anthracyclines -- administration & dosage
Antibodies, Monoclonal -- administration & dosage
Antibodies, Monoclonal -- adverse effects
Breast Neoplasms -- immunology
Breast Neoplasms -- mortality
Breast Neoplasms -- pathology
Breast Neoplasms -- physiopathology
Breast Neoplasms -- therapy
Drug Resistance, Neoplasm
Female
Heart Failure -- chemically induced
Humans
Oxidative Stress
Protein Kinase Inhibitors -- administration & dosage
Protein Kinase Inhibitors -- adverse effects
Quinazolines -- administration & dosage
Quinazolines -- adverse effects
Receptor, Epidermal Growth Factor -- antagonists & inhibitors
Receptor, erbB-2 -- antagonists & inhibitors
Receptor, erbB-2 -- immunology
Survival Rate
Ventricular Outflow Obstruction -- chemically induced
Note : Journal Article
Review
Langue :
  • Anglais
Identificateurs : urn:issn:1776-260X 
info:doi/10.1007/s11523-009-0112-2
info:pmid/19418111